Search Result "Avonex"
An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14 Issue: 6 Year: 2015 Page: 804-810
Author(s): Rodica Balasa,Smaranda Maier,Septimiu Voidazan,Adina Hutanu,Zoltan Bajko,Anca Motataianu
Assessment of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-Beta1 Serum Titers in Relapsing Remitting Multiple Sclerosis Patients Treated with Avonex, Possible Biomarkers for Treatment Response
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 1 Year: 2017 Page: 93-101
Author(s): Rodica Balasa,Smaranda Maier,Septimiu Voidazan,Adina Hutanu,Zoltan Bajko,Anca Motataianu,Brandusa Tilea,Cristina Tiu
Multiple Sclerosis: Pathogenesis and Treatment
Journal: Current Neuropharmacology
Volume: 9 Issue: 3 Year: 2011 Page: 409-416
Author(s): Ingrid Loma, Rock Heyman
Cytokines as Novel Therapeutic Agents for Neuroinflammatory Disorders: A Role for Interferon-β in the Treatment of Multiple Sclerosis
Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 1 Issue: 3 Year: 2001 Page: 201-208
Author(s): Moiz Bakhiet
Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11 Issue: 5 Year: 2012 Page: 610-623
Author(s): Monica Marta,Gavin Giovannoni
Gene Expression Studies in Multiple Sclerosis
Journal: Current Genomics
Volume: 8 Issue: 3 Year: 2007 Page: 181-189
Author(s): Lotti Tajouri, Francesca Fernandez, Lyn R. Griffiths
Epigenetic Drugs for Multiple Sclerosis
Journal: Current Neuropharmacology
Volume: 14 Issue: 1 Year: 2016 Page: 3-9
Author(s): Jacob Peedicayil
An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 29 Year: 2012 Page: 4475-4484
Author(s): Brigitte K. Paap,Alexander Hundeshagen,Michael Hecker,Uwe K. Zettl
Neuroprotective Methodologies in the Treatment of Multiple Sclerosis Current Status of Clinical and Pre-clinical Findings
Journal: Current Drug Discovery Technologies
Volume: 18 Issue: 1 Year: 2021 Page: 31-46
Author(s): Tarun Kapoor,Sidharth Mehan
Present Drug Therapy of Demyelinating Disorders
Journal: Current Drug Therapy
Volume: 13 Issue: 1 Year: 2018 Page: 25-42
Author(s): Yuval Karmon,Natan Gadoth